MXPA01009385A - Compuestos de triazolopirimidinol y sales de los mismos. - Google Patents
Compuestos de triazolopirimidinol y sales de los mismos.Info
- Publication number
- MXPA01009385A MXPA01009385A MXPA01009385A MXPA01009385A MXPA01009385A MX PA01009385 A MXPA01009385 A MX PA01009385A MX PA01009385 A MXPA01009385 A MX PA01009385A MX PA01009385 A MXPA01009385 A MX PA01009385A MX PA01009385 A MXPA01009385 A MX PA01009385A
- Authority
- MX
- Mexico
- Prior art keywords
- salts
- triazolopyrimidinol
- compounds
- compound
- haemorrhage
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- CJEBZUWYGIVECV-UHFFFAOYSA-N 7-[1-(4-chlorophenoxy)ethyl]-1h-[1,2,4]triazolo[1,5-a]pyrimidin-5-one Chemical compound C=1C(=O)N=C2N=CNN2C=1C(C)OC1=CC=C(Cl)C=C1 CJEBZUWYGIVECV-UHFFFAOYSA-N 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 206010010904 Convulsion Diseases 0.000 abstract 1
- 206010019196 Head injury Diseases 0.000 abstract 1
- 208000032843 Hemorrhage Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 208000030886 Traumatic Brain injury Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Se describen el 7-[1-(4-Clorofenoxi)etil]-1,2,4-triazol[1,5-a]pirimidin-5-ol aislado y sales farmaceuticamente aceptables del mismo, en la forma de enantiomeros individuales y mezclas de los mismos, incluyendo la mezcla racemica, formulaciones farmaceuticas que contienen este compuesto, y el uso de este compuesto en el tratamiento de ataques apopleticos, desordenes neurologicos tales como epilepsia, y/o condiciones en las que haya dano neurologico tales como ataque cerebral, trauma cerebral, lesiones en la cabeza y hemorragia.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9906124.4A GB9906124D0 (en) | 1999-03-18 | 1999-03-18 | Therapeutic agent |
| PCT/EP2000/001934 WO2000056733A1 (en) | 1999-03-18 | 2000-03-06 | Triazolopyrimidinol compounds and salts thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA01009385A true MXPA01009385A (es) | 2004-03-19 |
Family
ID=10849797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA01009385A MXPA01009385A (es) | 1999-03-18 | 2000-03-06 | Compuestos de triazolopirimidinol y sales de los mismos. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1183257A1 (es) |
| JP (1) | JP2002540110A (es) |
| CN (1) | CN1353714A (es) |
| AU (1) | AU3960700A (es) |
| CA (1) | CA2367899A1 (es) |
| GB (1) | GB9906124D0 (es) |
| MX (1) | MXPA01009385A (es) |
| WO (1) | WO2000056733A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9914743D0 (en) * | 1999-06-24 | 1999-08-25 | Knoll Ag | Therapeutic agents |
| EP3969639B1 (en) | 2019-05-13 | 2025-03-12 | Ecolab Usa Inc. | 1,2,4-triazolo[1,5-a] pyrimidine derivative as copper corrosion inhibitor |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321162D0 (en) * | 1993-10-13 | 1993-12-01 | Boots Co Plc | Therapeutic agents |
| GB9617727D0 (en) * | 1996-08-23 | 1996-10-02 | Knoll Ag | Process |
-
1999
- 1999-03-18 GB GBGB9906124.4A patent/GB9906124D0/en not_active Ceased
-
2000
- 2000-03-06 EP EP00918762A patent/EP1183257A1/en not_active Withdrawn
- 2000-03-06 AU AU39607/00A patent/AU3960700A/en not_active Abandoned
- 2000-03-06 CA CA002367899A patent/CA2367899A1/en not_active Abandoned
- 2000-03-06 CN CN00807525A patent/CN1353714A/zh active Pending
- 2000-03-06 WO PCT/EP2000/001934 patent/WO2000056733A1/en not_active Application Discontinuation
- 2000-03-06 MX MXPA01009385A patent/MXPA01009385A/es unknown
- 2000-03-06 JP JP2000606594A patent/JP2002540110A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002540110A (ja) | 2002-11-26 |
| CA2367899A1 (en) | 2000-09-28 |
| AU3960700A (en) | 2000-10-09 |
| EP1183257A1 (en) | 2002-03-06 |
| WO2000056733A1 (en) | 2000-09-28 |
| GB9906124D0 (en) | 1999-05-12 |
| CN1353714A (zh) | 2002-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2316921A1 (en) | Aryl fused azapolycyclic compounds | |
| CA2401229A1 (en) | Aryl fused azapolycyclic compounds | |
| IT1291372B1 (it) | Uso di analoghi eterociclici di 1,2,4-triazolo (1,5-c) pirimidine per la preparazione di medicamenti utili per il trattamento delle malattie | |
| AU2001273574A1 (en) | Substituted 5-alkynyl pyrimidines having neurotrophic activity | |
| CA2413424A1 (en) | Substituted bicyclic derivatives for the treatment of abnormal cell growth | |
| CA2358998A1 (en) | Substituted bicyclic derivatives useful as anticancer agents | |
| AU5752194A (en) | Benzimidazole compounds, their use and preparation | |
| IL127244A (en) | Substituted amines, methods of their preparation and pharmaceutical compositions containing them | |
| HUP9904525A2 (hu) | S-(-)-N-Propargil-1-amino-indán tartalmú neurológiai rendellenességek kezelésére alkalmas gyógyszerkészítmények | |
| CA2338220A1 (en) | Substituted imidazoles having cytokine inhibitory activity | |
| CA2181175A1 (en) | Dihydro Pyrazolopyrroles | |
| WO2001019829A3 (en) | Pyrazolopyrimidines as therapeutic agents | |
| CA2258548A1 (en) | Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases | |
| BG103417A (en) | Condensed pyrimidine bicyclic derivatives | |
| TW372237B (en) | 1-2-4 triazolo[1,5-a]pyrimidines, pharmaceutical compositions containing them for treatment and/or prophylaxis of seizures, neurological disorders and/or conditions in which there is neurological damage, and processes for their preparation | |
| CA2280447A1 (en) | Pyrrolo¬1,2-a|pyrazine derivatives as 5ht1a ligands | |
| PL314086A1 (en) | Novel (r)-8-fluoro-3-n,n-substituted amino 3,4-dihydro 5-carbamoyl-2h-1-bezopyranes | |
| MY133474A (en) | Aryl fused azapolycyclic compounds | |
| CA2314154A1 (en) | Azepine or larger medium ring derivatives and their use as pharmaceuticals | |
| RU94046141A (ru) | Замещенные производные /арилалкоксибензил/ аминопропанамида, способы их получения, фармацевтическая композиция | |
| MY108482A (en) | Compounds. | |
| GB9109972D0 (en) | Therapeutic compounds | |
| WO2004011464A3 (fr) | Nouvelles pyrazolo[1,5-a]-1,3,5-triazines substituees et leurs analogiques, compositions pharmaceutiques les contenant, utilisation a titre de medicament et procedes pour leur preparation | |
| GR3034354T3 (en) | IMIDAZO 1,2-a]QUINOXALIN-4-AMINES ACTIVE AS ADENOSINE ANTAGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
| AU3218393A (en) | N-substituted-dihydrobenzofuran derivatives as anti tumor compositions and methods of treatment |